Page last updated: 2024-10-30

metformin and Epilepsies, Partial

metformin has been researched along with Epilepsies, Partial in 1 studies

Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.

Epilepsies, Partial: Conditions characterized by recurrent paroxysmal neuronal discharges which arise from a focal region of the brain. Partial seizures are divided into simple and complex, depending on whether consciousness is unaltered (simple partial seizure) or disturbed (complex partial seizure). Both types may feature a wide variety of motor, sensory, and autonomic symptoms. Partial seizures may be classified by associated clinical features or anatomic location of the seizure focus. A secondary generalized seizure refers to a partial seizure that spreads to involve the brain diffusely. (From Adams et al., Principles of Neurology, 6th ed, pp317)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kim, JK1
Cho, J1
Kim, SH1
Kang, HC1
Kim, DS1
Kim, VN1
Lee, JH1

Other Studies

1 other study available for metformin and Epilepsies, Partial

ArticleYear
Brain somatic mutations in MTOR reveal translational dysregulations underlying intractable focal epilepsy.
    The Journal of clinical investigation, 2019, 10-01, Volume: 129, Issue:10

    Topics: Animals; Brain; Disease Models, Animal; Drug Resistant Epilepsy; Epilepsies, Partial; Female; Gene E

2019